Three-year key project receives 560,000 euros in funding
Researchers at the Institute of Pharmacy and Molecular Biotechnology of Heidelberg University are exploring new approaches to the treatment of diseases of the central nervous system such as Alzheimer's and brain tumours. In collaboration with a research team from the USA, Prof. Dr. Gert Fricker in the field of pharmaceutical technology and neurobiologist Prof. Dr. Ulrike Müller are developing transport systems that can penetrate the blood-brain barrier to "ferry" certain agents into the brain. The Else Kröner-Fresenius Foundation is funding the three-year key project with approximately 560,000 euros. Research work is scheduled to begin in April 2016.
The blood-brain barrier, which separates the central nervous system from circulating blood, is formed by the vascular walls of the cerebral capillaries and allows the free passage of only a few nutrients. The barrier is virtually impermeable especially to macromolecules like proteins, DNA and RNA. Yet it is precisely these molecules, known as biologicals, that Prof. Fricker indicates are highly interesting for treating Alzheimer's and aggressive brain tumours, the glioblastomas.
His working group has now developed special polymer nanoparticles with a modified surface that enables them to specifically dock onto and permeate the blood-brain barrier, after which they dissolve in the brain. Prof. Fricker explains that these particles can be loaded with low molecular agents, i.e., substances of low molecular weight. The particles then transport the otherwise disallowed substances into the central nervous system, where they reach the therapeutically necessary concentrations.
The underlying concept is now being applied to biologicals provided by Prof. Müller and her colleague Prof. Dr. Olivia Merkel of Wayne State University Detroit (USA). Ulrike Müller specialises in Alzheimer’s research. The Heidelberg neurobiologists and her working group supply the peptide APPsα, which protects the nerve cells and acts as an antagonist to the toxic ß amyloid. The ß amyloid deposits are thought to be one of the main causes of Alzheimer’s disease. Olivia Merkel and her research team are supplying the so-called small interfering RNA molecules. These short molecules of ribonucleic acid help turn off the expression of certain genes in brain tumours.
The charitable Else Kröner-Fresenius Foundation promotes the advancement of medical research. The foundation supports key projects with the potential to make fundamental and groundbreaking discoveries that could impact an entire field of research.
Prof. Dr. Gert Fricker and Prof. Dr. Ulrike Müller
Institute of Pharmacy and Molecular Biotechnology
Phone: +49 6221 54-8336 (Fricker) and -6717 (Müller)
Communications and Marketing
Press Office, phone: +49 6221 54-2311
Marietta Fuhrmann-Koch | idw - Informationsdienst Wissenschaft
Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory
Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP
Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.
Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
09.12.2016 | Life Sciences
09.12.2016 | Ecology, The Environment and Conservation
09.12.2016 | Health and Medicine